(Press-News.org)
The Synapsy Centre for Neuroscience Research in Mental at the University of Geneva (UNIGE) Faculty of Medicine has awarded its first prize to Professor Eric Nestler, a leading figure in the neurobiology of depression and addiction. The prize recognises a career dedicated to linking fundamental discoveries about the brain to concrete clinical advances in mental health.
Psychiatry has been evolving over the past twenty years. Driven by a new scientific ambition, it seeks to understand the biological mechanisms underlying mental disorders to improve their diagnosis and treatment. This translational approach aims to foster dialogue between neuroscience and psychiatry, two disciplines that are often compartmentalised. This shift is at the heart of the mission of the Synapsy Centre for Neuroscience Research in Mental Health (Synapsy Centre). Created in 2010 as a national research centre, Synapsy became a permanent faculty centre in 2022. And the stakes of its mission are enormous. In 2019, nearly 970 million people worldwide were living with a mental disorder, mainly anxiety and depression, according to the WHO. These diseases significantly reduce life expectancy and impact society as a whole. They require new approaches to combat them, and it all starts with research. The Synapsy Prize was created to recognise those who contribute to bridging the gap between research and clinical reality. It’s an honorary award and a sum of money dedicated to the person. Its very first winner, Eric Nestler, MD, PhD, researcher and Anne and Joel Ehrenkranz dean at the Icahn school of medicine at Mount Sinai (New York) perfectly embodies this approach.
Research between two worlds
Eric Nestler has devoted his career to exploring the biological basis of depression and addiction. His pioneering work has shown how stress and addictive substances permanently alter gene expression in the brain, affecting the neural circuits involved in reward and mood. “Eric Nestler was one of the first to demonstrate that it is not only possible, but necessary, to build solid bridges between fundamental neuroscience and clinical psychiatry,” emphasises Christian Lüscher, professor at UNIGE, Director of Synapsy and chair of the award committee. “His career perfectly embodies Synapsy’s vision of brain research that is open to society and works to alleviate psychological suffering.”
The author of more than 700 publications, Eric Nestler has had a lasting influence on his discipline, notably by bringing a dynamic vision of resilience, the mental ability to adapt to difficulties and bounce back after stressful or traumatic situations. “We have shown that resilience is not simply an absence of vulnerability, but an active process, a molecular programme that can be stimulated and strengthened, particularly to cope with depression,” he explains.
The importance of training
Trained as both a psychiatrist and a neuroscientist, Eric Nestler has always made the link between experimental models and clinical realities. “We start with human observations to design animal experiments, which we then validate on post-mortem brain tissue from patients, before returning to animal models to generate novel approaches for eventual clinical applications,” he summarises. Several mechanisms identified by this rigorous translational method have now reached the clinical trial stage. “To advance mental health, tomorrow’s research laboratories will have to bring together molecules, cells, circuits, and behaviours, and establish causal links across these different scales,” he adds.
For him, like the Synapsy approach, this new translational strategy to research is not enough on its own. “We also need to create a genuine scientific ecosystem by training hybrid researchers who are capable of navigating between clinical research in psychiatry and fundamental research in neuroscience,” he explains.
Propelling a new ecosystem
“Mental health has suffered for too long from a divide between research and clinical practice,” says Christian Lüscher. “With Synapsy, we want to create a space for collaboration and trust, where disciplines enrich each other. This is how we can develop a modern form of psychiatry, based on the mechanisms of the brain, but focused on the needs of patients.”
By honouring Eric Nestler, the Synapsy Centre wishes to pay tribute to a scientist whose work has inspired an entire generation and paved the way for more precise and effective treatments based on clinical observations made on humans.
END
Emotional support is an increasingly common reason people turn to generative artificial intelligence chatbots and wellness applications, but these tools currently lack the scientific evidence and the necessary regulations to ensure users’ safety, according to a new health advisory by the American Psychological Association.
The APA Health Advisory on the Use of Generative AI Chatbots and Wellness Applications for Mental Health examined consumer-focused technologies that people are relying on for mental health advice and treatment, ...
The unforeseen consequences of modern lifestyles are coming to the forefront as healthcare costs spike in developed countries worldwide. One method to mitigate this is to encourage walking to promote good health. Therefore, initiatives to increase daily steps have been taking shape and becoming subjects for in-depth study.
Dr. Haruka Kato, a junior associate professor at Osaka Metropolitan University, with policy planners from the Sakai City Government investigated the ...
LOS ANGELES — Keck Hospital of USC and USC Verdugo Hills Hospital (USC-VHH) each earned a Fall 2025 “A” Hospital Safety Grade from The Leapfrog Group, an independent national nonprofit focused on patient safety. The hospitals are part of Keck Medicine of USC, the University of Southern California’s health system.
“This is the first time the health system has received two ‘A’s simultaneously, which is a huge accomplishment,” said Rod Hanners, CEO of Keck Medicine. “The Leapfrog Group grades hospitals ...
Affective computing, proposed by Picard in 1997, aims to endow computational systems with the ability to recognize, interpret, and respond to human emotions. Early studies relied primarily on behavioral cues such as facial expressions and voice tone for modelling affective states.
Affective computing has entered a new phase—wearable devices are capable of continuously acquiring multimodal physiological signals from multiple sensor channels that differ in terms of sampling frequency, physiological origin, and signal characteristics.
In ...
A newly discovered, carnivorous lizard ostensibly represents what most casual onlookers would perhaps perceive to be a dinosaur; however, it is in fact a precursor of the modern crocodile.
Named Tainrakuasuchus bellator, partially derived from Latin meaning for “warrior” or “fighter”, this armour-plated reptile lived 240 million years ago just before the dinosaurs.
And, as a Pseudosuchia (the precursors of modern crocodiles and alligators), it was among a group of the top, most dominant predators of its time in the Triassic Period.
This particular new species – detailed, today, in the peer-reviewed Journal of Systematic Palaeontology – was approximately ...
As artificial vision systems evolve, bridging the gap between sensing and processing remains a key challenge. Now, researchers from the University of Science and Technology of China, led by Prof. Yong Yan and Prof. Haiding Sun, have developed a reconfigurable bioinspired vision sensor using GaN/AlN quantum-disk-in-nanowires (QD-NWs) that emulates the human retina’s dual-cell system—delivering in-sensor computing for high-accuracy human action recognition (HAR).
Why This Bioinspired Sensor Matters
Dual-Mode ...
Nuclear fusion, which operates on the same principle that powers the Sun, is expected to become a sustainable energy source for the future. To achieve fusion power generation, it is essential to confine plasma at temperatures exceeding one hundred million degrees using a magnetic field and to maintain this high-energy state stably. A key factor in accomplishing this is the electric potential inside the plasma. This potential governs the transport of particles and energy within the plasma and plays a crucial role in establishing a state in which energy is effectively confined and prevented ...
CHAMPAIGN, Ill. — A naturally occurring protein that tends to be expressed at higher levels in breast cancer cells boosts the effectiveness of some anticancer agents, including doxorubicin, one of the most widely used chemotherapies, and a preclinical drug known as ErSO, researchers report. The protein, FGD3, contributes to the rupture of cancer cells disrupted by these drugs, boosting their effectiveness and enhancing anticancer immunotherapies.
The discovery is described in the Journal of Experimental & Clinical Cancer Research.
The new findings were the happy result of experiments involving ErSO, an experimental drug that killed 95-100% of estrogen-receptor-positive ...
A widely-used, inexpensive gout drug could reduce heart attacks and strokes in people with cardiovascular disease, according to a new Cochrane review.
The review examined the effects of low doses of colchicine, a drug used to treat gout, and found no increase in serious side effects.
Cardiovascular disease is often driven by chronic low-grade inflammation, which contributes to recurrent cardiovascular events such as heart attacks and strokes. Colchicine has anti-inflammatory properties that make it a promising option for people with heart disease.
A promising effect on cardiovascular risk
The review included 12 randomized controlled trials involving nearly 23,000 ...
EMBARGOED: Hold for release until Wednesday, Nov. 12 at 18:30 ET / 23:30 UK time
Headache disorders affect 3 billion people worldwide—nearly one in every three people, ranking sixth for health loss in 2023
Women experienced more than twice the headache-related health loss of men and spent a greater share of their lives with headache symptoms.
Migraine caused nearly 90% of all disability linked to headache disorders, even though tension-type headache was more common.
More than one-fifth of the global headache burden ...
